177 related articles for article (PubMed ID: 21272753)
41. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.
Li X; Yang J; Wang X; Xu Q; Zhang Y; Yin T
Thromb Res; 2015 Apr; 135(4):621-9. PubMed ID: 25628141
[TBL] [Abstract][Full Text] [Related]
42. VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children.
Biss TT; Avery PJ; Brandão LR; Chalmers EA; Williams MD; Grainger JD; Leathart JB; Hanley JP; Daly AK; Kamali F
Blood; 2012 Jan; 119(3):868-73. PubMed ID: 22010099
[TBL] [Abstract][Full Text] [Related]
43. A review of a priori regression models for warfarin maintenance dose prediction.
Francis B; Lane S; Pirmohamed M; Jorgensen A
PLoS One; 2014; 9(12):e114896. PubMed ID: 25501765
[TBL] [Abstract][Full Text] [Related]
44. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
45. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
Avery PJ; Jorgensen A; Hamberg AK; Wadelius M; Pirmohamed M; Kamali F;
Clin Pharmacol Ther; 2011 Nov; 90(5):701-6. PubMed ID: 22012312
[TBL] [Abstract][Full Text] [Related]
46. Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
Xu H; Xie X; Wang B; Chen Y; Meng T; Ma S; Wang F
Int J Cardiol; 2014 Dec; 177(2):654-7. PubMed ID: 25449474
[No Abstract] [Full Text] [Related]
47. Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.
Obeng AO; Kaszemacher T; Abul-Husn NS; Gottesman O; Vega A; Waite E; Myers K; Cho J; Bottinger EP; Ellis SB; Scott SA
Clin Pharmacol Ther; 2016 Nov; 100(5):427-430. PubMed ID: 27393744
[TBL] [Abstract][Full Text] [Related]
48. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
Meijer K; Kim YK; Carter D; Schulman S
Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
[TBL] [Abstract][Full Text] [Related]
49. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the predictive performance of Bayesian dosing for warfarin in Chinese patients.
Dong J; Shi GH; Lu M; Huang S; Liu YH; Yao JC; Li WY; Li LX
Pharmacogenomics; 2019 Feb; 20(3):167-177. PubMed ID: 30777785
[TBL] [Abstract][Full Text] [Related]
51. Clinical verification of Lou type warfarin pharmacokinetic dosing algorithms equation.
Jiang J; Ji N; Lan J; Ge X; Du X
Mol Med Rep; 2018 Apr; 17(4):6144-6149. PubMed ID: 29436624
[TBL] [Abstract][Full Text] [Related]
52. Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study).
Filippelli A; Signoriello S; Bancone C; Corbi G; Manzo V; Iesu S; Politi C; Gigantino A; De Donato MT; Masiello P; Simeon V; Della Corte A; Cellurale M; Conti V; Frigino M; Ciarambino T; Marracino M; Carpenito L; Ferrara N; De Feo M; Gallo C
Pharmacogenomics J; 2020 Jun; 20(3):451-461. PubMed ID: 31801992
[TBL] [Abstract][Full Text] [Related]
53. Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
Scott SA; Lubitz SA
Pharmacogenomics; 2014 Apr; 15(6):719-22. PubMed ID: 24897277
[TBL] [Abstract][Full Text] [Related]
54. Use of signals and systems engineering to improve the safety of warfarin initiation.
Hyun G; Li J; Bass AR; Mohapatra A; Woller SC; Lin H; Eby C; McMillin GA; Gage BF
J Thromb Thrombolysis; 2016 Nov; 42(4):529-33. PubMed ID: 27443162
[TBL] [Abstract][Full Text] [Related]
55. Hematology consult: high-sensitivity warfarin genotype.
Schwer C; Lamana S; Dasanu CA
Conn Med; 2013; 77(10):581-5. PubMed ID: 24367840
[TBL] [Abstract][Full Text] [Related]
56. A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation.
Pengo V; Zambon CF; Fogar P; Padoan A; Nante G; Pelloso M; Moz S; Frigo AC; Groppa F; Bozzato D; Tiso E; Gnatta E; Denas G; Padayattil Jose S; Padrini R; Basso D; Plebani M
PLoS One; 2015; 10(12):e0145318. PubMed ID: 26710337
[TBL] [Abstract][Full Text] [Related]
57. Validation and comparison between two warfarin dosing clinical algorithms and warfarin fixed dosing in specialized heart center: cross-sectional study.
Elnour AA; Ahmed IM; Khalid AK; Elmustafa M
Pharm Pract (Granada); 2022; 20(3):2722. PubMed ID: 36733524
[TBL] [Abstract][Full Text] [Related]
58. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration.
Santos PC; Marcatto LR; Duarte NE; Gadi Soares RA; Cassaro Strunz CM; Scanavacca M; Krieger JE; Pereira AC
Pharmacogenomics; 2015 Jul; 16(8):865-76. PubMed ID: 26050796
[TBL] [Abstract][Full Text] [Related]
59. Dosage individualization of warfarin using artificial neural networks.
Saleh MI; Alzubiedi S
Mol Diagn Ther; 2014 Jun; 18(3):371-9. PubMed ID: 24574079
[TBL] [Abstract][Full Text] [Related]
60. Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithm.
Asiimwe IG; Blockman M; Cohen K; Cupido C; Hutchinson C; Jacobson B; Lamorde M; Morgan J; Mouton JP; Nakagaayi D; Okello E; Schapkaitz E; Sekaggya-Wiltshire C; Semakula JR; Waitt C; Zhang EJ; Jorgensen AL; Pirmohamed M
CPT Pharmacometrics Syst Pharmacol; 2022 Jan; 11(1):20-29. PubMed ID: 34889080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
